September 13, 2018

Meet with Selexis Scientific and Business Leaders at Several Upcoming Industry Conferences and Events

Read More
July 10, 2018

Symphogen A/S and Selexis Expand Relationship as Symphogen Advances its Monoclonal Antibody (mAb) Mixture Pipeline

Read More
June 12, 2018

ProMIS Neurosciences Initiates Manufacturing of PMN310, its Lead Therapeutic Antibody for Treatment of Alzheimer’s Disease

Read More

Media Downloads